Filing Details
- Accession Number:
- 0001225208-14-024353
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-03 16:57:54
- Reporting Period:
- 2014-12-01
- Filing Date:
- 2014-12-03
- Accepted Time:
- 2014-12-03 16:57:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1385187 | Covidien Plc | COV | Surgical & Medical Instruments & Apparatus (3841) | 980624794 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1603289 | E Michael Tarnoff | C/O Covidien 15 Hampshire Street Mansfield MA 02048 | Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2014-12-01 | 11,882 | $0.00 | 36,168 | No | 4 | A | Direct | |
| Ordinary Shares | Disposition | 2014-12-01 | 976 | $100.99 | 35,192 | No | 4 | F | Direct | |
| Ordinary Shares | Disposition | 2014-12-01 | 8,000 | $100.99 | 27,192 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2014-12-02 | 428 | $101.61 | 26,764 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct |
Footnotes
- Restricted stock units vest in equal installments on each of the first, second, third and fourth anniversary of the grant date and are settled in ordinary shares upon vesting. The Reporting Person will receive dividend equivalent stock units in connection with this award.
- Includes 38 dividend equivalent units paid on existing restricted stock unit awards following the date of the Reporting Person's last Form 4 filing.
- The price reported is the weighted average price. Shares were sold in multiple transactions at prices ranging from $100.97 to $101.05. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, full information regarding the number of shares sold at each price.
Billionaire Hedge Funds
